# Meritage Homes CORP: overview

MTH · NYSE · CIK 833079 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mth.md) · [Financials](/companies/mth/financials.md) · [Filings](/companies/mth/filings.md) · [Insiders](/companies/mth/insiders.md)

Latest reported revenue: [$1.41bn](/filings/0001437749-22-018107.md) for Q2 FY2022, three months to 2022-06-30, from the 10-Q filed Jul 29, 2022 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-22-018107).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.67](/filings/0000833079-25-000138.md) | not reported | [1.69](/filings/0000833079-26-000105.md) | [2.04](/filings/0000833079-26-000128.md) | [1.39](/filings/0000833079-25-000138.md) | not reported | [0.82](/filings/0000833079-26-000105.md) | [1.37](/filings/0000833079-26-000128.md) |
| Free cash flow | $m | [(100) d](/filings/0000833079-25-000138.md) | [(107) d](/filings/0000833079-26-000010.md) | [(48.2)](/filings/0000833079-26-000105.md) | [6.9 d](/filings/0000833079-26-000128.md) | [(104) d](/filings/0000833079-25-000138.md) | [238 d](/filings/0000833079-26-000010.md) | [97.0](/filings/0000833079-26-000105.md) | [184 d](/filings/0000833079-26-000128.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [19.29](/filings/0000833079-24-000015.md) | [13.37](/filings/0000833079-25-000021.md) | [9.96](/filings/0000833079-26-000010.md) | [10.72](/filings/0000833079-26-000010.md) | [6.35](/filings/0000833079-26-000010.md) |
| Free cash flow | $m | [(178)](/filings/0000833079-24-000015.md) | [378](/filings/0000833079-25-000021.md) | [317](/filings/0000833079-26-000010.md) | [(256)](/filings/0000833079-26-000010.md) | [92.6](/filings/0000833079-26-000010.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mth/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.03bn | 12,228,015 |  | Added +503,452 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $339.3m | 4,046,067 |  | Added +78,631 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $328.4m | 3,916,619 |  | Added +328,569 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $301.4m | 3,594,997 |  | Added +140,265 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $242.8m | 2,896,044 |  | Added +13,234 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $240.9m | 2,873,406 |  | Reduced −4,562 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $171.2m | 2,042,101 |  | Added +54,251 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $154.2m | 1,839,080 |  | Added +438,051 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $144.1m | 1,718,277 |  | Added +56,536 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $121.0m | 1,443,063 |  | Added +45,274 |

## Recent filings

[All 1,168 filings](/companies/mth/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:31 ET | [10-Q](/filings/0000833079-26-000135.md) | Quarterly report, period 2026-09-30 | 0000833079-26-000135 |
| 2026-10-28 | 16:31 ET | [8-K](/filings/0000833079-26-000133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000833079-26-000133 |
| 2026-08-25 | 16:30 ET | [8-K](/filings/0000833079-26-000130.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000833079-26-000130 |
| 2026-07-31 | 16:36 ET | [10-Q](/filings/0000833079-26-000128.md) | Quarterly report, period 2026-06-30 | 0000833079-26-000128 |
| 2026-07-29 | 16:30 ET | [8-K](/filings/0000833079-26-000125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000833079-26-000125 |
| 2026-06-29 | 16:30 ET | [8-K](/filings/0000833079-26-000122.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000833079-26-000122 |
| 2026-05-21 | 16:37 ET | [8-K](/filings/0000833079-26-000113.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000833079-26-000113 |
| 2026-04-24 | 16:20 ET | [10-Q](/filings/0000833079-26-000105.md) | Quarterly report, period 2026-03-31 | 0000833079-26-000105 |
| 2026-04-22 | 16:30 ET | [8-K](/filings/0000833079-26-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000833079-26-000103 |
| 2026-04-07 | 16:21 ET | [DEF 14A](/filings/0000833079-26-000098.md) | Proxy statement, period 2025-12-31 | 0000833079-26-000098 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000833079-26-000010.md), filed Feb 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 833079
- Tickers: MTH
- Exchange: NYSE
- SIC code: 1531 Operative Builders
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:41 ET. No prices; not investment advice.